Jul 17, 2023 / 12:30PM GMT
Operator
Good morning, everyone, and welcome to the argenx ADHERE trial top line results conference call. (Operator Instructions)
I would now like to introduce Beth DelGiacco, Vice President of Investor Relations and Communications at argenx. Beth, please proceed.
Beth DelGiacco - argenx SE - VP and Global Head of Corporate Communications & IR
Thank you, and good morning to everyone on the call. Earlier today, we issued the press release summarizing over positive top line and ADHERE trail results. The press release and the presentation for today's webcast can be found on our website. On the call today are Tim Van Hauwermeiren our Chief Executive Officer; Luc Truyen our Chief Medical Officer; and Karen Massey, our Chief Operating Officer. Karl Gubitz, our Chief Financial Officer, will also be available for the Q&A session following prepared remarks.
Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development,
argenx SE To Discuss the Adhere Results Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers